• NHS-Biotin (A8002): Precision Protein Biotinylation for Rese

  2026-05-05

  NHS-Biotin (N-hydroxysuccinimido biotin) enables stable, site-specific biotinylation of antibodies and proteins via primary amines. Its short, uncharged spacer arm supports efficient intracellular and multimeric protein labeling, making it valuable for detection and purification in biochemical workflows. APExBIO’s NHS-Biotin (A8002) meets demanding research needs requiring minimal steric hindrance and high sensitivity.

• Mechanisms of Spiroplasma eriocheiris Entry into Drosophila

  2026-05-05

  This study elucidates how Spiroplasma eriocheiris invades Drosophila Schneider 2 cells, identifying clathrin-mediated endocytosis and macropinocytosis as key pathways. These findings inform experimental approaches to pathogen-host interactions and highlight potential intervention points in cell signaling relevant to infection biology.

• Lnc21q22.11 Suppresses Gastric Cancer via MEK/ERK Inhibition

  2026-05-04

  This study identifies Lnc21q22.11 as a novel long non-coding RNA that inhibits gastric cancer progression by interfering with the MEK/ERK signaling pathway. The findings highlight the mechanistic link between epigenetic regulation of lncRNAs and tumor suppression, with implications for future targeted therapies.

• Applied Workflows with LEE011 Succinate: Advancing CDK Inhib

  2026-05-04

  Ribociclib succinate (LEE011 succinate) empowers researchers with robust, reproducible cell cycle inhibition capabilities in HER2-positive metastatic breast cancer models. This guide delivers hands-on protocol enhancements, troubleshooting strategies, and key lessons from contemporary research—optimizing your use of this selective CDK inhibitor from APExBIO.

• Vardenafil HCl Trihydrate: Precision Tools for PDE5 Assays

  2026-05-03

  Vardenafil HCl Trihydrate empowers researchers to dissect cGMP signaling and smooth muscle relaxation with unmatched selectivity and reproducibility. Leveraging recent proteoform-specific insights, this guide details optimized workflows, troubleshooting strategies, and advanced assay applications for phosphodiesterase research.

• Optimal RIP3 Stoichiometry Tunes Necrosome Signal in Necropt

  2026-05-02

  This study reveals that necrosome assembly relies on a precise stoichiometry of RIP3 to RIP1, optimizing signal amplification and attenuation during necroptosis. Quantitative imaging and modeling uncover how supramolecular organization sets the threshold for cell death, offering new frameworks for dissecting regulated cell death and informing therapeutic modulation.

• Cy5-UTP (Cyanine 5-UTP): Precision RNA Labeling for Stable,

  2026-05-01

  Explore how Cy5-UTP (Cyanine 5-uridine triphosphate) empowers researchers with robust, sensitive, and stable RNA labeling for advanced transcriptomic applications. This article uniquely examines the interplay between fluorescent RNA probe synthesis and the latest innovations in mRNA delivery and storage stability.

• Ampicillin Sodium: β-Lactam Antibiotic for Advanced Research

  2026-05-01

  Ampicillin sodium's high purity and robust inhibition of bacterial cell wall biosynthesis underpin its status as an indispensable β-lactam antibiotic for genetic selection, antibacterial activity assays, and resistance modeling. This article delivers applied workflows, troubleshooting insights, and protocol refinements, leveraging the unique strengths of APExBIO's Ampicillin sodium (A2510).

• RBMS1 Loss Enables PD-L1 Blockade in Triple-Negative Breast

  2026-04-30

  This study reveals that loss of the RNA-binding protein RBMS1 destabilizes PD-L1 by disrupting its glycosylation, thereby enhancing anti-tumor immune responses in triple-negative breast cancer (TNBC). The findings provide a mechanistic basis for combining RBMS1 targeting with immune checkpoint blockade therapies to improve immunotherapy outcomes in TNBC.

• Applied Workflows for JNJ-26481585 (Quisinostat) in Cancer R

  2026-04-30

  JNJ-26481585 (Quisinostat) is transforming cancer research workflows by offering potent, selective HDAC inhibition for robust apoptosis induction, cell cycle arrest, and drug resistance reversal. Explore optimized protocols, troubleshooting strategies, and evidence-driven applications that leverage this epigenetic modulator’s unique properties across diverse tumor models.

• Bedaquiline: Mechanistic Leverage in TB and Cancer Metabolis

  2026-04-29

  Explore how the diarylquinoline antibiotic bedaquiline uniquely empowers translational research at the crossroads of multi-drug resistant tuberculosis and cancer metabolism. This thought-leadership article delivers a mechanistic deep dive, actionable protocol guidance, and a forward-looking vision, drawing on recent host-directed therapy advances and validated workflow benchmarks.

• Biotin-16-UTP: Precision RNA Labeling for Mechanistic Studie

  2026-04-29

  Biotin-16-UTP unlocks highly specific, reproducible RNA labeling, powering advanced RNA detection, purification, and interaction mapping. Its optimized performance accelerates workflows in lncRNA research and RNA-protein interaction assays, with proven utility in cancer biology.

• ONX-0914 (PR-957): Precision Immunoproteasome Inhibition Wor

  2026-04-28

  ONX-0914 (PR-957) stands out as a potent, selective LMP7 inhibitor for immunoproteasome research, enabling reproducible cytokine blockade and disease modeling. This article translates cutting-edge evidence into actionable protocols, advanced troubleshooting, and comparative guidance for autoimmune and neuroinflammatory studies.

• Partial BACE Inhibition Lowers Amyloid Beta Without Synaptic

  2026-04-28

  Satir et al. (2020) demonstrate that moderate inhibition of β-secretase (BACE) can reduce amyloid β production by up to 50% without impairing synaptic transmission in cultured neurons. This finding refines the therapeutic window for Alzheimer's disease interventions targeting amyloid pathways and informs future clinical trial design.

• HyperScribe T7 High Yield Cy3 RNA Labeling Kit: Workflow & I

  2026-04-27

  The HyperScribe T7 High Yield Cy3 RNA Labeling Kit empowers researchers with robust, high-yield fluorescent probe synthesis for advanced spatial and gene expression assays. This article decodes its experimental advantages, practical workflow enhancements, and troubleshooting tips—translating new mechanistic insights from recent sepsis research into actionable laboratory strategies.

15251 records 2/1017 page Previous Next 12345 下5页 Last page